SCHEMBL5818193

SCHEMBL5818193

CC(C)(C)c1ccc(C=CCO)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.55
▸ ALDH1A1 P00352 3/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ LMNA P02545 4/20 0.43
▸ TYR P14679 1/20 0.43
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ TRPV1 Q8NER1 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ GRIN2D O15399 2/20 0.42
▸ GRIN3B O60391 2/20 0.42
▸ GRIN1 Q05586 2/20 0.42
▸ GRIN2A Q12879 2/20 0.42
▸ GRIN2B Q13224 2/20 0.42
▸ GRIN2C Q14957 2/20 0.42
▸ GRIN3A Q8TCU5 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5801550 1.00 CYP1A2 (0.55) CYP1A2ALDH1A1CYP3A4RECQLLMNA
SCHEMBL6495364 0.82 RXRB (0.47) CYP1A2ALDH1A1CYP3A4RECQLSMN1; SMN2
SCHEMBL6495369 0.82 RXRB (0.47) CYP1A2ALDH1A1CYP3A4RECQLSMN1; SMN2
SCHEMBL6497958 0.82 PPARG (0.46) CYP1A2ALDH1A1CYP3A4RECQLLMNA
SCHEMBL9276383 0.82 ALDH1A1 (0.62) CYP1A2ALDH1A1CYP3A4RECQLLMNA
SCHEMBL9276381 0.82 ALDH1A1 (0.62) CYP1A2ALDH1A1CYP3A4RECQLLMNA
SCHEMBL19417348 0.81 CYP1A2 (0.52) CYP1A2ALDH1A1LMNATYRNPC1
SCHEMBL29025957 0.81 CYP1A2 (0.52) CYP1A2ALDH1A1LMNATYRNPC1
SCHEMBL1825729 0.79 CYP1A2 (0.64) CYP1A2ALDH1A1LMNATYRNPC1
SCHEMBL1825727 0.79 CYP1A2 (0.64) CYP1A2ALDH1A1LMNATYRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108947754-B Use of bidentate phosphite ligands in C-F bond building reactions 郑州大学 2021-02-26 — — CN claimed
CN-108993600-B Use of bidentate phosphite ligands in C-B bond building reactions 郑州大学 2021-01-22 — — CN claimed
CN-108993600-A Application of the bidentate phosphite ester ligand in the building reaction of C-B key 郑州大学 2018-12-14 — — CN claimed
CN-108947754-A Application of the bidentate phosphite ester ligand in the building reaction of C-F key 郑州大学 2018-12-07 — — CN claimed
CN-113429249-B Method for synthesizing chiral 4-hydroxy amino acid derivative 陕西师范大学 2023-06-16 — — CN disclosed
CN-113429249-A Method for synthesizing chiral 4-hydroxy amino acid derivative 陕西师范大学 2021-09-24 — — CN disclosed
CN-108947754-B Use of bidentate phosphite ligands in C-F bond building reactions 郑州大学 2021-02-26 — — CN disclosed
CN-108993600-B Use of bidentate phosphite ligands in C-B bond building reactions 郑州大学 2021-01-22 — — CN disclosed
CN-108993600-A Application of the bidentate phosphite ester ligand in the building reaction of C-B key 郑州大学 2018-12-14 — — CN disclosed
CN-108947754-A Application of the bidentate phosphite ester ligand in the building reaction of C-F key 郑州大学 2018-12-07 — — CN disclosed
WO-2006098554-A1 NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-21 — — WO disclosed
Send feedback